Exencial Wealth Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$367K Sell
652
-22
-3% -$14.1K 0.01% 451
2025
Q4
$456K Buy
674
+14
+2% +$9.53K 0.01% 409
2025
Q3
$421K Buy
660
+10
+2% +$6.07K 0.01% 408
2025
Q2
$349K Buy
650
+4
+0.6% +$1.91K 0.01% 420
2025
Q1
$271K Buy
646
+16
+3% +$6.95K 0.01% 437
2024
Q4
$260K Sell
630
-11
-2% -$4.83K 0.01% 449
2024
Q3
$324K Buy
641
+11
+2% +$5.34K 0.01% 425
2024
Q2
$307K Sell
630
-2
-0.3% -$1K 0.01% 426
2024
Q1
$341K Sell
632
-6
-0.9% -$3.28K 0.01% 421
2023
Q4
$354K Buy
638
+6
+0.9% +$2.82K 0.01% 403
2023
Q3
$276K Buy
632
+13
+2% +$6.48K 0.01% 373
2023
Q2
$311K Sell
619
-344
-36% -$165K 0.01% 361
2023
Q1
$482K Sell
963
-9
-0.9% -$4.31K 0.02% 286
2022
Q4
$397K Buy
972
+214
+28% +$83.1K 0.02% 322
2022
Q3
$247K Buy
758
+4
+0.5% +$1.47K 0.01% 362
2022
Q2
$264K Buy
754
+3
+0.4% +$1.22K 0.01% 364
2022
Q1
$411K Buy
+751
New +$395K 0.02% 309
2021
Q3
Sell
-998
Closed -$630K 380
2021
Q2
$630K Buy
998
+303
+44% +$167K 0.03% 280
2021
Q1
$340K Sell
695
-225
-24% -$113K 0.02% 336
2020
Q4
$460K Sell
920
-300
-25% -$134K 0.03% 250
2020
Q3
$480K Buy
1,220
+200
+20% +$73.9K 0.03% 259
2020
Q2
$337K Buy
+1,020
New +$295K 0.03% 254
2020
Q1
Sell
-820
Closed -$214K 253
2019
Q4
$214K Hold
820
0.04% 251
2019
Q3
$223K Sell
820
-210
-20% -$58.4K 0.05% 228
2019
Q2
$284K Buy
+1,030
New +$254K 0.07% 184

Other funds holding IDXX

Exencial Wealth Advisors's IDXX Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Idexx Laboratories (IDXX) stake by 3.3% in Q1 2026, selling an estimated $14.1K and leaving 652 shares worth $367K. The position accounts for 0.01% of the portfolio, ranked #451.

Exencial Wealth Advisors first reported a position in IDXX in Q2 2019 and has held it in 25 quarters since. The position peaked at $630K in Q2 2021. 1,316 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Exencial Wealth Advisors held 652 shares of Idexx Laboratories worth $367K as of Q1 2026.
  • Exencial Wealth Advisors sold 22 Idexx Laboratories shares in Q1 2026, an estimated $14.1K.
  • Idexx Laboratories made up 0.01% of Exencial Wealth Advisors's portfolio in Q1 2026, its #451 holding.
  • Exencial Wealth Advisors first reported a position in Idexx Laboratories in Q2 2019 and has held it in 25 quarters since.
  • Exencial Wealth Advisors's Idexx Laboratories position peaked at $630K in Q2 2021.
  • 1,316 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.